GATA2 zinc finger 1 mutations are associated with distinct clinico-biological features and outcomes different from GATA2 zinc finger 2 mutations in adult acute myeloid leukemia-Reference-Cited by-同舟云学术

GATA2 zinc finger 1 mutations are associated with distinct clinico-biological features and outcomes different from GATA2 zinc finger 2 mutations in adult acute myeloid leukemia

Published:2018-08-31 Issue:9 Volume:8 Page:
ISSN:2044-5385
Container-title:Blood Cancer Journal
language:en
Short-container-title:Blood Cancer Journal

Author:

Tien Feng-Ming^ORCID,Hou Hsin-An,Tsai Cheng-Hong^ORCID,Tang Jih-Luh,Chiu Yu-Chiao^ORCID,Chen Chien-Yuan,Kuo Yuan-Yeh,Tseng Mei-Hsuan,Peng Yen-Ling,Liu Ming-Chih,Liu Chia-Wen,Liao Xiu-Wen,Lin Liang-In,Lin Chien-Ting,Wu Shang-Ju,Ko Bor-Sheng^ORCID,Hsu Szu-Chun,Huang Shang-Yi,Yao Ming,Chou Wen-Chien,Tien Hwei-Fang

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Hematology

Link

http://www.nature.com/articles/s41408-018-0123-2.pdf

Reference39 articles.

1. Tsai, F. Y. et al. An early haematopoietic defect in mice lacking the transcription factor GATA-2. Nature 371, 221–226 (1994).

2. Tsai, F. Y. & Orkin, S. H. Transcription factor GATA-2 is required for proliferation/survival of early hematopoietic cells and mast cell formation, but not for erythroid and myeloid terminal differentiation. Blood 89, 3636–3643 (1997).

3. Zhang, S. J. et al. Gain-of-function mutation of GATA-2 in acute myeloid transformation of chronic myeloid leukemia. Proc. Natl Acad. Sci. USA 105, 2076–2081 (2008).

4. Hahn, C. N. et al. Heritable GATA2 mutations associated with familial myelodysplastic syndrome and acute myeloid leukemia. Nat. Genet. 43, 1012–1017 (2011).

5. Wlodarski, M. W. et al. Prevalence, clinical characteristics, and prognosis of GATA2-related myelodysplastic syndromes in children and adolescents. Blood 127, 1387–1397 (2016).

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic significance of GATA2 in patients with MDS/AML: a systematic review and meta-analysis;Annals of Hematology;2024-07-19

2. CEBPA mutations in acute myeloid leukemia: implications in risk stratification and treatment;International Journal of Hematology;2024-04-26

3. Germline predisposition to myeloid neoplasms: Characteristics and management of high versus variable penetrance disorders;Best Practice & Research Clinical Haematology;2024-03

4. <i>GATA2 </i>mutant variant allele frequency may reflect prognosis in Chinese adult patients with de novo cytogenetically normal acute myeloid leukemia;Biomolecules and Biomedicine;2024-02-27

5. Clonal hematopoiesis in children with predisposing conditions;Seminars in Hematology;2024-02